Oxolife raises €5.1M Series B round
15 June 2025· Barcelona, Spain· health, biotech, pharmaceuticals, fertility, b2b
The funding will be used to accelerate the progress of the lead program OXO-001 through clinical trials and kick off Phase II PCOS trials
Investors
LeadInveready
About Oxolife
Headquarters
Barcelona, Spain
Founded
2013
Team Size
6–20
Sectors
healthbiotechpharmaceuticalsfertilityb2b
Source: https://femtechinsider.com/oxolife-pcos-ivf-implantation/